Highly Commended Consumer Involvement Paper

CT:IQ and the Australian Clinical Trials Alliance (ACTA) are pleased to announce a prestigious award for an innovative coauthored publication that focused on their development of a toolkit to support meaningful consumer involvement in clinical trials in Australia. The paper, titled ‘Development of the Consumer Involvement & Engagement Toolkit: a digital resource to build capacity […]

CT:IQ Welcomes NT Health to Steering Committee

We are pleased to welcome CT:IQ’s first representative from Northern Territory to join our Steering Committee: NT Health. NT Health manages the Northern Territory public health system, operating across five service delivery regions, six hospitals, 74 health clinics and seven corporate offices. NT Health works together as one system in partnership with individuals, families, the community, […]

CT:IQ welcomes newest Steering Committee Member, Fortrea

CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee. Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing […]

ObvioHealth joins CT:IQ Steering Committee

CT:IQ is thrilled to announce our newest Steering Committee member, ObvioHealth. ObvioHealth, a virtual research organisation (VRO), brings a wealth of experience and expertise in conducting decentralised clinical trials (DCTs) that produce stronger therapeutic evidence. Its mission is to conduct innovative and efficient trials using technology to capture more robust and accurate data—so life-improving innovations […]

CSIRO joins CT:IQ’s Steering Committee

We are thrilled to announce CT:IQ’s newest Steering Committee member: CSIRO. As Australia’s national science agency, CSIRO’s purpose is to solve Australia’s greatest challenges through innovative science and technology. CSIRO works with industry, government and the research community to turn science into solutions, addressing issues including food security and quality; sustainable energy and resources; health […]

CT:IQ Welcomes Ramsay Health Care

We are pleased to welcome CT:IQ’s newest member, Ramsay Health Care. Founded in 1964, Ramsay is now one of the largest and most diverse private healthcare companies in the world, employing more than 88,000 people and treating millions of people every year. Ramsay offers quality healthcare through hundreds of facilities and community services in Australia, […]

Welcome MinterEllison to CT:IQ Steering Committee

We are delighted to welcome a new member to CT:IQ’s Steering Committee, MinterEllison. MinterEllison is one of Australia’s largest law firms, with nearly 200 years of business history. MinterEllison partners with clients to provide integrated, innovative solutions. Its teams collaborate across Australia, Asia and the UK to deliver exceptional service and new insight to a […]

CT:IQ welcomes Roche to Steering Committee

We are delighted to welcome a new member to CT:IQ’s Steering Committee, Roche. Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data-driven medical insights help Roche deliver truly personalised healthcare. […]

AccessCR joins CT:IQ Steering Committee

We are pleased to announce AccessCR has joined CT:IQ’s Steering Committee. AccessCR is a social enterprise providing services to the research sector to engage with and involve health consumers in research and development with a view to helping improve the relevance, efficiency of, and participant experience in, clinical trials that lead to advancements in health […]